STAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 million

CREATE Medicines, a biotech company, raises $122 million to develop CAR-T therapies, expanding its pipeline and researching autoimmune diseases. The company was cofounded by Siddhartha Mukherjee and recently rebranded from Myeloid Therapeutics. This funding will propel the company's first CAR-T candidates through human trials.